WNT4 and hyperandrogenism: Since WNT4 is also necessary to prevent formation of Leydig cells in women, patients with mutated WNT4 also present with clinical hyperandrogenism, rendering it a slightly different clinical entity (Biason-Lauber et al., 2004, 2007; Philibert et al., 2008).